title: Hot flashes: a review of pathophysiology and treatment modalities.
abstract: Many therapies are being studied for the treatment of hot flashes for individuals with cancer, yet few studies have demonstrated safe and effective clinical benefit for those who suffer from this distressing symptom. The purpose of this paper is to assess the current options for the management of hot flashes, examining key endpoints from recent clinical trials and reviewing future directions. Hot flashes are a common stressful symptom for individuals with cancer, particularly women with a history of breast cancer and men with prostate cancer. Lifestyle modifications are proposed as the first step in the management of less severe hot flashes. Several publications have addressed nonhormonal agents as a treatment option for hot flashes. Newer antidepressant and anticonvulsant agents have been studied and show potential in treating vasomotor symptoms. Although many complementary and alternative therapies, including herbal medications and phytoestrogens, have been studied for the treatment of hot flashes, none are clinically recommended at this time. Additionally, further evidence is needed for supportive exercise such as yoga and relaxation techniques. Acupuncture may warrant further investigation in the reduction and severity of hot flashes in both men and women. Hormonal therapies, including estrogens and progestogens, are the most well-known and efficient agents in alleviating hot flashes; however, the safety of these agents is disputable.
authors: Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. pmorrow@mdanderson.org
authors: Phuong Khanh H
authors: PK
authors: Morrow
authors: Danielle N
authors: DN
authors: Mattair
authors: Gabriel N
authors: GN
authors: Hortobagyi
mesh_terms: D001943:Breast Neoplasms / Q000503:physiopathology* / Q000628:therapy*; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D019584:Hot Flashes / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D008297:Male; D008593:Menopause / Q000502:physiology; D008875:Middle Aged; D011372:Progestins / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000503:physiopathology* / Q000628:therapy*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic
chemical_list: D004967:Estrogens; D011372:Progestins